Remarkable results have come from studies on the effect of MDMA-Assisted Psychotherapy on veterans with post-traumatic stress disorder (PTSD). Government-approved research, organized and funded by MAPS, shows that this approach can be an effective treatment for people who do not respond to traditional therapies for PTSD. MAPS' ongoing study of U.S. military veterans, firefighters, and police officers is halfway complete, and early results are promising.
From the MAPS website:
In a recently completed study, 83% of subjects receiving MDMA-assisted psychotherapy no longer qualified for PTSD, and everyone who received a placebo and then went on to receive MDMA-assisted psychotherapy experienced significant and lasting improvements. These results were published in the Journal of Psychopharmacology. These subjects had suffered from PTSD for an average of 19 years.
A long-term follow-up of subjects receiving MDMA-assisted psychotherapy revealed that overall benefits were maintained on average for 3½ years or more.